Currently, Dozee touches a million patients on an annualized basis across 300 hospitals in the US and India. It aims to touch ...

Jon Swope, a Barclays managing director, says some lessons learned in the healthcare industry will set the next wave of IPOs ...

The healthtech sector is experiencing a recalibration in valuations, as the industry is showing signs of early recovery with investments stabilizing and artificial intelligence (AI) driving new growth ...

The Public Sector Digital Transformation Awards were held at the Round Room of the Mansion House on Thursday, October 10 ...

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) shareholders today approved the proposal by the Board of Directors to appoint Deloitte Accountants B.V. as new independent auditor of the ...

Explore Shawn Lesser's impact investing roots and his mission to improve mental health with The REAL Mental Health Foundation ...

A Bristol healthtech firm that has developed novel eye imaging chip technology has secured £860,000 in its latest funding ...

TGIF, Agents of Impact! Help us help you amplify your impact. Join other Agents of Impact and ImpactAlpha’s team of editors ...

OUTCOMESAI, a healthtech startup, on Thursday (Oct 17) announced a partnership with SingHealth to integrate its artificial ...

The rapid growth of AI and crypto startups in India has sparked significant interest, as these sectors expand at an ...

Detailed price information for Kovo Healthtech Corp (KOVO-X) from The Globe and Mail including charting and trades.

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") shareholders today approved the proposal by the Board of Directors to appoint Deloitte ...